PTBP1 and osteosarcoma: An analysis performed on a Cancer Genome Atlas (TCGA) data set demonstrated an upregulation of CTR1 in response to RNA-binding protein (PTBP1) inhibition, enhancing osteosarcoma cells’ chemosensitivity to cisplatin [60].